DaVita
DVA
#1523
Rank
C$20.74 B
Marketcap
C$323.22
Share price
2.24%
Change (1 day)
66.30%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.63. In 2025 the company made an earnings per share (EPS) of C$14.38 a decrease over its 2024 EPS that were of C$15.67.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.155.35%
2025C$14.38-8.25%
2024C$15.6744.94%
2023C$10.8127.26%
2022C$8.50-35.56%
2021C$13.1944.1%
2020C$9.1519.7%
2019C$7.64540.48%
2018C$1.19-76.07%
2017C$4.99-19.31%
2016C$6.18242.52%
2015C$1.80-62.87%
2014C$4.8613.43%
2013C$4.288.45%
2012C$3.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.54 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$16.14 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$27.64 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.74-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA